We are live on ! Find out more
CRBU icon

Caribou Biosciences

104 hedge funds and large institutions have $313M invested in Caribou Biosciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 18

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

88% more call options, than puts

Call options by funds: $352K | Put options by funds: $187K

12% more funds holding

Funds holding: 93104 (+11)

4.61% more ownership

Funds ownership: 51.61%56.22% (+4.6%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

33% less capital invested

Capital invested by funds: $465M → $313M (-$151M)

Holders
104
Holders Change
+11
Holders Change %
+11.83%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
23
Increased
43
Reduced
18
Closed
11
Calls
$352K
Puts
$187K
Net Calls
+$165K
Net Calls Change
+$76K
Name Holding Trade Value Shares
Change
Change in
Stake
TWA
101
TCI Wealth Advisors
Arizona
$1K
FCA
102
FinTrust Capital Advisors
South Carolina
$1K +$1.05K +100 New
TWC
103
TD Waterhouse Canada
Ontario, Canada
$277
Coatue Management
104
Coatue Management
New York
-$8.41M -557,669 Closed
CCM
105
CloudAlpha Capital Management
Hong Kong
-$6.26M -415,000 Closed
Victory Capital Management
106
Victory Capital Management
Texas
-$1.23M -81,160 Closed
Squarepoint
107
Squarepoint
New York
-$1.16M -76,691 Closed
PVI
108
Pura Vida Investments
New York
-$633K -41,932 Closed
E
109
Ergoteles
New York
-$626K -41,487 Closed
DekaBank Deutsche Girozentrale
110
DekaBank Deutsche Girozentrale
Germany
-$321K -22,000 Closed
AI
111
Atom Investors
Texas
-$246K -16,323 Closed
RA
112
Royce & Associates
New York
-$195K -12,900 Closed
KC
113
KCL Capital
New York
-$181K -12,000 Closed
EVM
114
Eaton Vance Management
Massachusetts
-$6K -425 Closed
SOW
115
State of Wyoming
Wyoming
-$1.32K -125 -79%

CRBU Hedge Fund Activity: Q1 2022 in Review

104 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2022, worth a combined $313M — down 33% from $465M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CRBU positions and 11 closed out — a net gain of 12 holders — while 43 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $16.4M. The largest seller was Fidelity Investments, cutting an estimated $13.8M.

  • 104 institutional investors held Caribou Biosciences (CRBU) as of Q1 2022, up from 93 in Q4 2021.
  • Funds reported $313M of Caribou Biosciences stock for Q1 2022, down 33% quarter-over-quarter.
  • 23 funds opened new Caribou Biosciences positions in Q1 2022 and 11 closed out, a net change of +12 holders.
  • The largest Caribou Biosciences buyer in Q1 2022 was BlackRock, an estimated $16.4M added.
  • The largest Caribou Biosciences seller in Q1 2022 was Fidelity Investments, an estimated $13.8M sold.

Based on aggregated 13F filings for Q1 2022.